Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study

Daniel Ayoubkhani, Kamlesh Khunti, Vahé Nafilyan, Thomas Maddox, Ben Humberstone, Sir Ian Diamond, Amitava Banerjee
doi: https://doi.org/10.1101/2021.01.15.21249885
Daniel Ayoubkhani
1Office for National Statistics, Newport, UK
Roles: Principal Statistician
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: daniel.ayoubkhani@ons.gov.uk
Kamlesh Khunti
2Diabetes Research Centre, University of Leicester, Leicester, UK
Roles: Professor of Primary Care Diabetes and Vascular Medicine and Co-Director of the Leicester Diabetes Centre
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vahé Nafilyan
1Office for National Statistics, Newport, UK
Roles: Principal Statistician
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Maddox
1Office for National Statistics, Newport, UK
Roles: Statistician
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ben Humberstone
1Office for National Statistics, Newport, UK
Roles: Deputy Director of Health Analysis and Life Events Division
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sir Ian Diamond
1Office for National Statistics, Newport, UK
Roles: UK National Statistician
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amitava Banerjee
3Institute of Health Informatics, University College London, London, UK
4University College London Hospitals NHS Trust, London, UK
5Barts Health NHS Trust, The Royal London Hospital, London, UK
Roles: Associate Professor of Clinical Data Science and Honorary Consultant Cardiologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives The epidemiology of post-COVID syndrome (PCS) is currently undefined. We quantified rates of organ-specific impairment following recovery from COVID-19 hospitalisation compared with those in a matched control group, and how the rate ratio (RR) varies by age, sex, and ethnicity.

Design Observational, retrospective, matched cohort study.

Setting NHS hospitals in England.

Participants 47,780 individuals (mean age 65 years, 55% male) in hospital with COVID-19 and discharged alive by 31 August 2020, matched to controls on demographic and clinical characteristics.

Outcome measures Rates of hospital readmission, all-cause mortality, and diagnoses of respiratory, cardiovascular, metabolic, kidney and liver diseases until 30 September 2020.

Results Mean follow-up time was 140 days for COVID-19 cases and 153 days for controls. 766 (95% confidence interval: 753 to 779) readmissions and 320 (312 to 328) deaths per 1,000 person-years were observed in COVID-19 cases, 3.5 (3.4 to 3.6) and 7.7 (7.2 to 8.3) times greater, respectively, than in controls. Rates of respiratory, diabetes and cardiovascular events were also significantly elevated in COVID-19 cases, at 770 (758 to 783), 127 (122 to 132) and 126 (121 to 131) events per 1,000 person-years, respectively. RRs were greater for individuals aged <70 than ≥ 70 years, and in ethnic minority groups than the White population, with the biggest differences observed for respiratory disease: 10.5 [9.7 to 11.4] for <70 years versus 4.6 [4.3 to 4.8] for ≥ 70 years, and 11.4 (9.8 to 13.3) for Non-White versus 5.2 (5.0 to 5.5) for White.

Conclusions Individuals discharged from hospital following COVID-19 face elevated rates of multi-organ dysfunction compared with background levels, and the increase in risk is neither confined to the elderly nor uniform across ethnicities. The diagnosis, treatment and prevention of PCS require integrated rather than organ- or disease-specific approaches. Urgent research is required to establish risk factors for PCS.

Competing Interest Statement

All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; KK is Chair of the Ethnicity Subgroup of the Independent Scientific Advisory Group for Emergencies (SAGE), a member of Independent SAGE, a Trustee of the South Asian Health Foundation (SAHF), and Director of the University of Leicester Centre for Black Minority Ethnic Health; and AB is a Trustee of the SAHF, and has received a research grant unrelated to the current work from AstraZeneca.

Funding Statement

There was no external funding for this study.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical approval was obtained from the National Statistician's Data Ethics Advisory Committee [NSDEC(20)12].

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • daniel.ayoubkhani{at}ons.gov.uk, kk22{at}leicester.ac.uk, vahe.nafilyan{at}ons.gov.uk, thomas.maddox{at}ons.gov.uk, ben.humberstone{at}ons.gov.uk, ian.diamond{at}statistics.gov.uk, ami.banerjee{at}ucl.ac.uk

Data Availability

In accordance with NHS Digital's Information Governance (IG) requirements, it is not possible for the study data to be shared.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted January 15, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study
Daniel Ayoubkhani, Kamlesh Khunti, Vahé Nafilyan, Thomas Maddox, Ben Humberstone, Sir Ian Diamond, Amitava Banerjee
medRxiv 2021.01.15.21249885; doi: https://doi.org/10.1101/2021.01.15.21249885
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study
Daniel Ayoubkhani, Kamlesh Khunti, Vahé Nafilyan, Thomas Maddox, Ben Humberstone, Sir Ian Diamond, Amitava Banerjee
medRxiv 2021.01.15.21249885; doi: https://doi.org/10.1101/2021.01.15.21249885

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (76)
  • Allergy and Immunology (199)
  • Anesthesia (54)
  • Cardiovascular Medicine (492)
  • Dentistry and Oral Medicine (90)
  • Dermatology (57)
  • Emergency Medicine (169)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (214)
  • Epidemiology (5719)
  • Forensic Medicine (3)
  • Gastroenterology (217)
  • Genetic and Genomic Medicine (871)
  • Geriatric Medicine (88)
  • Health Economics (232)
  • Health Informatics (767)
  • Health Policy (395)
  • Health Systems and Quality Improvement (254)
  • Hematology (105)
  • HIV/AIDS (185)
  • Infectious Diseases (except HIV/AIDS) (6522)
  • Intensive Care and Critical Care Medicine (393)
  • Medical Education (118)
  • Medical Ethics (28)
  • Nephrology (93)
  • Neurology (851)
  • Nursing (44)
  • Nutrition (142)
  • Obstetrics and Gynecology (164)
  • Occupational and Environmental Health (263)
  • Oncology (516)
  • Ophthalmology (164)
  • Orthopedics (44)
  • Otolaryngology (107)
  • Pain Medicine (48)
  • Palliative Medicine (21)
  • Pathology (149)
  • Pediatrics (252)
  • Pharmacology and Therapeutics (147)
  • Primary Care Research (114)
  • Psychiatry and Clinical Psychology (980)
  • Public and Global Health (2249)
  • Radiology and Imaging (378)
  • Rehabilitation Medicine and Physical Therapy (174)
  • Respiratory Medicine (313)
  • Rheumatology (109)
  • Sexual and Reproductive Health (82)
  • Sports Medicine (82)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (34)
  • Urology (42)